β-Sitosterol Reduces the Expression of Chemotactic Cytokine Genes in Cystic Fibrosis Bronchial Epithelial Cells

Extracts from Nigella arvensis L. seeds, which are widely used as anti-inflammatory remedies in traditional medicine of Northern Africa, were able to inhibit the expression of the pro-inflammatory neutrophil chemokine Interleukin (IL)-8 in Cystic Fibrosis (CF) bronchial epithelial IB3-1 cells exposed to the Gram-negative bacterium Pseudomonas aeruginosa. The chemical composition of the extracts led to the identification of three major components, β-sitosterol, stigmasterol, and campesterol, which are the most abundant phytosterols, cholesterol-like molecules, usually found in plants. β-sitosterol (BSS) was the only compound that significantly reproduced the inhibition of the P. aeruginosa-dependent expression of IL-8 at nanomolar concentrations. BSS was tested in CF airway epithelial CuFi-1 cells infected with P. aeruginosa. BSS (100 nM), showed a significant and consistent inhibitory activity on expression of the P. aeruginosa-stimulated expression chemokines IL-8, GRO-α GRO-β, which play a pivotal role in the recruitment of neutrophils in CF inflamed lungs. Preliminary mechanistic analysis showed that BSS partially inhibits the P. aeruginosa-dependent activation of Protein Kinase C isoform alpha, which is known to be involved in the transmembrane signaling activating IL-8 gene expression in bronchial epithelial cells. These data indicate BSS as a promising molecule to control excessive lung inflammation in CF patients.


INTRODUCTION
Medicinal plants are attracting a renewed interest, since they have been a classical source of drugs for different human diseases (Newman and Cragg, 2016). This interest is particularly actual as the introduction of new drugs is now largely adopting the repurposing strategy to overcome the bottlenecks of pharmaceutical development (Strittmatter, 2014), a strategy that includes the natural medicinal products as potential repurposing source (Cragg et al., 2014). By serendipity, we focused our attention on the seeds obtained from the plant Nigella arvensis (N. arvensis), that is commonly known in native populations of Northern Africa and Asia as curative plant in traditional medicine, as its black seeds have been in use as natural remedy for over twenty centuries. The plant Nigella is a genre of different species, including N. sativa, N. damascena, and N. arvensis. Few findings were reported about extracts derived from N. arvensis or active principles identified in this species, while N. sativa was the object of different studies, reporting on different biological effects including its anti-inflammatory activities (Khader and Eckl, 2014). Regarding the possible anti-inflammatory effects of extracts derived from Nigella species, it has been published that N. sativa has therapeutic and anti-oxidant effects during lipopolysaccharide (LPS)-induced in vivo inflammation (Entok et al., 2014). The major biological effects of N. sativa are attributed to its characterized constituents, including thymoquinone, the most prominent constituent of N. sativa seeds. Thymoquinone is capable to reduce pro-inflammatory cytokine levels (Bai et al., 2014). In addition to thymoquinone, Nigella seeds contain sterols, proteins, alkaloids, saponins, and essential oils (Khader and Eckl, 2014).
Cystic Fibrosis (CF) is a severe genetic disease due to defects of the CF Transmembrane Conductance Regulator (CFTR) gene, affecting several organs. Chronic pulmonary disease is the leading cause of reduced quality and expectancy of life (Pittman et al., 2014). It is well established that chronic infection sustained by the Gram-negative bacterium Pseudomonas aeruginosa (P. aeruginosa) is a hallmark of CF lung disease, which is associated with an excessive lung inflammation characterized by huge infiltrate of neutrophils in the bronchial lumen, mainly due to the release of the neutrophil chemokine IL-8 (Bonfield et al., 1995;Khan et al., 1995;Puchelle et al., 2001;Belcher and Vij, 2010). The research regarding modern therapies to neutralize the inflammation in CF patients is aimed at finding new putative anti-inflammatory drugs displaying different mechanisms of action, in order to replace corticosteroids or ibuprofen, which posses many well-known and important side effects in addition to the great predicted benefits (Cantin et al., 2015).
The large use of the "black seeds of the desert" to mitigate the respiratory symptoms in Northern African children affected by recurrent or chronic bronchial inflammatory diseases (as anecdotal example see Supplementary Text S1), prompted us to ascertain the potential anti-inflammatory properties of these seeds. Due to the unmet need of novel anti-inflammatory drugs for chronic lung disease of CF patients, we tested the chloroform extract and the major chemical components of these seeds in CF bronchial epithelial cells, which are known to play a pivotal role in IL-8 expression and in the inflammatory response in this condition (Prandini et al., 2016). We identified N. arvensis as the plant originating the seeds utilized in current medicinal practice, observing that its chloroform extract is effective to reduce the expression of the key neutrophilic chemokine IL-8 in CF bronchial epithelial cells, upon exposure to P. aeruginosa. Among the major chemical components isolated from the seeds of N. arvensis, only β-sitosterol (BSS) was able to inhibit the expression of the neutrophil chemokines IL-8, GRO-α, and GRO-β, likely interfering with the protein kinase C-mediated signaling. These results indicate BSS as a promising molecule to control excessive lung inflammation in CF patients.

Extraction of Chemical Components from Nigella arvensis Seeds
Seeds of N. arvensis L. (Ranunculaceae) were purchased from a Berberian pharmacy in Northern Africa (Morocco). N. arvensis dried seeds (5.0 g) were milled in a blade grinder (0.2 mm mesh; Fritsch, Idar-Oberstein, Germany). The flour was extracted with 50 ml of hexane through ultrasound assisted maceration (20 min at 25 • C), then filtered and centrifuged (3,000 rpm, 20 min). The residue was extracted with 50 ml of chloroform with the same procedure, was then re-extracted twice with 25 ml of the same solvent, for two times. All the supernatants were dried with rotary evaporator.

Separation and Identification of Chemical Components by GC-MS Analysis
The chloroform extract was analyzed by a Varian GC-3800 gas chromatograph equipped with a Varian MS-4000 mass spectrometer (MS) using electron impact and hooked to NIST library. The column used was a Varian FactorFour VF-5ms poly-5% phenyl-95%-dimethyl-siloxane bonded phase (i.d., 0.25 mm; length, 30 m; film thickness, 0.25 µm). Operating conditions for determination of chloroform extract composition were as follows: injector temperature, 300 • C; carrier (helium) flow rate, 1.5 mL/min and split ratio, 1:50. Oven temperature was increased from 230 to 320 • C at a rate of 5 • C/min, followed by 7 min at 320 • C. The MS conditions were: ionization voltage, 70 eV; emission current, 10 mAmp; scan rate, 1 scan/s; mass range, 29-600 Da; trap temperature, 150 • C, transfer line temperature, 300 • C. One microliter of each sample was injected. The constituents were identified by comparing their relative retention time (KI) and the MS fragmentation patterns with pure compounds (BSS, stigmasterol, and campesterol; Sigma-Aldrich), by matching with the above mentioned mass spectra library and with those in the literature (Adams, 2007). Samples were analyzed in Gas Chromatography -Flame Ionization Detector (GC-FID) for quantitative assessment through the normalization method, without using correction factors. The relative peak areas for individual constituents were averaged on three different chromatograms. The relative percentages were determined using a ThermoQuest GC-Trace gas-chromatograph equipped with a FID detector maintained at 300 • C; all the others GC conditions were the same of GC-MS method.

Proliferation Assay
IB3-1 or CuFi-1 cells were seeded at a density of 200,000 cells in 24 well plates in LHC-8 medium in the presence of 5% FBS. After adhesion, N. arvensis extract was added at serial dilutions (as indicate in the figures) and incubated for further 24 h or 48 h. Cells were washed with PBS, detached with trypsin/EDTA and resuspended in DMEM medium. Finally, cells were counted with a Sysmex XE-2100 Cytometer.

Anti-bacterial Assay
The anti-microbial activity of N. arvensis extracts was determined by following the procedure for the Minimum Inhibitory Concentration (MIC) of the Clinical and Laboratory Standards Institute (CLSI), former National Committee for Clinical Laboratory Standards (NCCLS). Briefly, P. aeruginosa (PAO1 strain) was cultured on agar plates of TSA overnight at 37 • C. The range of N. arvensis extract concentration tested (as indicated in the figure) was prepared in 15 ml tubes containing 5 ml of TSB. A McFarland 0.5 standard concentration of P. aeruginosa (20 µl) was added to each tube and the samples were incubated at 37 • C for 24 h. MIC is defined as the lowest concentration of compound at which there is no visible organism growth. In order to verify the absence of bacterial growth, the samples were read at 660 nm wavelength for quantitative analysis with a Beckman DU 640 spectrophotometer.
Adherence of PAO1 to IB3-1 Cells PAO1 were metabolically labeled with [ 35 S]-methionine according to (Saiman and Prince, 1993) with minor changes, as described (Dechecchi et al., 2008). Colonies of PAO1 from overnight TSA plates were inoculated M9 (Difco, Detroit, MI, USA) medium and grown at 37 • C with shaking to a density of 10 8 CFU/ml. 100 mCi/ml [35S] methionine (Amersham Biosciences, Uppsala, Sweden) was added to the broth and incubated at 37 • C with shaking for 30 min. Bacteria were then washed twice with 10 mM NaCl and resuspended in PBS. Aliquots of bacterial suspension were plated and scintillations counted to calculate the number of bacteria associated with the counts per minute (CFU/cpm). Specific activity ranged between 40 and 1000 CFU/cpm. Metabolically labeled PAO1 were added to monolayers of IB3-1 cells and incubated at room temperature for 60 min. Unbound organisms were rinsed off the monolayers with three successive PBS washes. Cells and adherent bacteria were solubilized in 0.5 ml of 2% SDS and scintillations were counted. Specific binding was calculated by subtracting counts obtained in the presence of 100-fold excess unlabelled PAO1. Non-specific binding was about 30% of total.

Quantitative Expression Cytokine Release
IB3-1 cells seeded on 24 wells Petri dishes were treated with vehicle alone or BSS for 16 h and then infected with PAO1 for Frontiers in Pharmacology | www.frontiersin.org  further 4 h. Quantitative measurement of Il-8 protein release in the cell medium was measured by the Human IL-8 Instant ELISA kit (Bender MedSystems, Vienna, Austria). Cytokines released from CuFi-1 cells into tissue culture supernatants were measured by Magnetic Luminex Assay (R&D SYSTEMS, Minneapolis, MN, USA) as suggested by the manufacturer. The Luminex assay is designed for the multiplexed quantitative measurement of multiple cytokines in a single well using as little as 50 µl of sample. In our experiments, the Human Premixed Multi-Analyte Kit (R&D SYSTEMS) for the IL-8, GRO-α, GRO-β human cytokines analysis was used. 50 µl of cytokine standards or samples (supernatants recovered from treated cells) were incubated with 50 µl of anti-cytokine conjugated magnetic beads in 96-well plates for 2 h at room temperature with shaking. Plates were washed three times with 100 µl of Bio-Plex wash buffer using Bio-Plex Pro-wash Station (Bio-Rad laboratories, Hercules, CA, USA), 50 µl of diluted detection antibody were added, and plates were incubated for 1 h at room temperature with shaking. After three washes, 50 µl of streptavidin-phycoerythrin was added, and the plates were incubated for 30 min at room temperature with shaking. Finally, plates were washed three times, beads were suspended in Bio-Plex wash buffer, and samples were analyzed on a Bio-Plex 200 Array reader (Bio-Rad). Data were analyzed with Bio-Pex Manager software (Bio-Rad).

PKCα Translocation and Microscopic Analysis
IB3-1 cells were seeded and then transfected with the Protein Kinase C isoform alpha fused to green fluorescence protein (PKCαGFP), using Lipofectamine LTX, as previously described (Chiesa et al., 2001). Microscope analysis was performed 36 h after transfection, P. aeruginosa strain 1:100 CFU was added to the cells, as shown in the figure. Images of PKCα translocation were recorded a different time points using a digital imaging system based on a Zeiss Axiovert 200 fluorescence microscope. The data were acquired and processed using the MetaMorph analysis program (Universal Imaging). The recruitment of the kinase is represented as plasma membrane translocation of PKCαGFP, expressed as percentage of the increase in fluorescence ratio with respect to time 0 (calculated as the ratio of plasma membrane and cytosol average intracellular fluorescence, obtained from multiple regions inside the cytosol and on the cell membrane, measured on single cell). The values are expressed as fold change vs. uninfected PAO1 control cells (0 min), referred as 100%. Indeed, the PKCα translocation was quantified by using representative line scan profile of fluorescence intensity across the cell, indicated by white diagonal lines in "0 min" and "60 min" images reported in the figure.

Statistics
Results are expressed as mean ± standard error of the mean (SEM). Comparisons between groups were made by using Student's t-test. Statistical significance was defined for * p < 0.05, * * p < 0.01, * * * p < 0.001.

Major Chemical Composition of N. arvensis Extract
Chloroform extract from milled N. arvensis seeds was analyzed. Several chemical compounds were identified as principal constituents of N. arvensis extracts, including BSS, stigmasterol, and campesterol (Figure 1). This identification procedure was performed by GC-MS analysis of chloroform extracts of N. arvensis. BSS, stigmasterol, and campesterol are phytosterols, cholesterol-like molecules found in plant material with the highest concentrations occurring in vegetable oils. Phytosterols act as structural components in the vegetal cell membrane, a role that is played by cholesterol in mammalian cells. The extraction yield was 0.94%. The chemical fingerprinting of N. arvensis extracts was achieved by GC-MS. The main phytosterols were identified by comparison between the experimental peaks and the standards molecules peaks analyzed with the same technique. The phytocomplex obtained by the chloroform extraction exhibited an important phytosterols component, constituted by stigmastan-3,5-diene (tentatively identified), campesterol, stigmasterol, and BSS, the latter being the most abundant compound, as reported in Table 1.

Inhibition of IL-8 mRNA Expression in IB3-1 Cells Infected by P. aeruginosa and Treated with N. arvensis Extract
In order to study the possible anti-inflammatory effect of N. arvensis seeds, we firstly tested different concentrations of the extract in CF bronchial epithelial IB3-1 cells infected with the P. aeruginosa laboratory strain PAO1. The neutrophil chemokine IL-8 transcript was quantified. As shown in Figure 2A, the extract significantly inhibited, the PAO1-dependent transcription of IL-8 in IB3-1 cells by approximately 50%, starting from 2 µg/ml. The inhibitory effect of the N. arvensis extract was tested after different incubation times. The N. arvensis extract (10 µg/ml) was added to IB3-1 cells 24, 4, and 2 h before, simultaneously or 2 h post PAO1 infection (100 CFU/cell). The inhibitory effect was confirmed in all these conditions, as shown in Figure 2B.
These findings indicate that extract of N. arvensis seeds reduces the inflammatory response to P. aeruginosa in CF bronchial cells.

Extract from N. arvensis Has No Effect on Cell Growth in IB3-1 Cells
In order to exclude possible adverse effects on cell cycle, cell growth was studied in IB3-1 cells treated with the extract (1-200 µg/ml) for 24 or 48 h. No changes in cell growth were observed in IB3-1 cells treated with the N. arvensis extract (Figure 2E), also at high concentration (200 µg/ml). These data indicate that the extract of N. arvensis does not affect the proliferation of IB3-1 cells.

Extract from N. arvensis Does Not Affect PAO1 Growth and Adherence to IB3-1 Cells
To exclude that the inhibition of P. aeruginosa-dependent induction of IL-8 was due to an indirect anti-bacterial effect on P. aeruginosa, we performed an anti-bacterial assay following the procedure for the MIC. Bacteria were cultured overnight at 37 • C in the presence of solvent or ranging doses (0.1-1000 µg/ml) of N. arvensis extract. As shown in Figure 2C, no effect on bacterial growth was found, indicating that N. arvensis does not possess significant anti-bacterial activity on the Gram-negative bacterium P. aeruginosa. Considering that many pathogenic microorganisms use glycoconjugate receptors to establish contact with the host tissues (McNamara et al., 2006), the inhibition of biosynthesis of these receptors may have a major impact on the pathogenesis of infection and, consequently, on the host response induced by infection. Therefore, the anti-inflammatory effect of N. arvensis extract observed in IB3-1 cells could reflect the reduced expression of glycolipid receptors for PAO1. To evaluate this possibility, adherence of metabolically labeled [ 35 S] methionine-PAO1 was measured in IB3-1 cells, treated or not for 24 h with the extract of N. arvensis (10 µg/ml). Figure 2D shows a dose-dependent increase of PAO1 binding to the cells, no significant differences due to the treatment with N. arvensis could be found. These results indicate that incubation with N. arvensis extract for 24 h does not affect the adherence of PAO1 to IB3-1 cells, thus suggesting that the sharp inhibition of P. aeruginosa-dependent IL-8 transcription after treatment with N. arvensis is independent from reduction of bacterial-host cell interactions.

Extract of N. arvensis Reduces P. aeruginosa Dependent IL-8 Expression in IB3-1 Cells
We extended the analysis of the anti-inflammatory effect to other genes known to be involved in the host-pathogen interaction in CF bronchial epithelial cells (Dechecchi et al., 2011). As shown in Figure 3, infection with the P. aeruginosa strain PAO1 for 4 h up-modulated the expression of the major neutrophil chemokines IL-8, GRO-α, and GRO-β, of the mononuclear cells chemokine IP-10, of the adhesion molecule intercellular adhesion molecule 1 (ICAM-1) involved in leukocyte chemotaxis, of the cytokines IL-1β, IL-6, TNF-α, IFN-γ, of the antimicrobial peptides β-defensin-2 (HBD-2) and -4 (HBD-4) and of lactoperoxidase (LPO). IL-8, the most abundantly expressed cytokine in the lung of CF patients, was

BSS Reduces P. aeruginosa-Dependent
Inflammatory Response in CF Bronchial Epithelial Cells β-sitosterol, stigmasterol, and campesterol were the three major compounds identified in the extract from the seeds of N. arvensis, as shown in Figure 1. These compounds were purchased and tested in IB3-1 cells in order to identify those reproducing the anti-inflammatory activity observed with the whole extract. The IB3-1 cells were treated with increasing doses, starting from 1 nM BSS, stigmasterol, and campesterol for 16 h before infection with PAO1. As shown in Figure 4A, BSS significantly inhibited the PAO1-dependent transcription of IL-8, starting from 10 nM concentration. No effect on the transcription of IL-8 was found in cells treated with stigmasterol or campesterol (data not shown). In order to check whether changes in IL-8 mRNA was directly translated into protein level, secretion of IL-8 protein was measured in cell supernatants. As shown in Figure 4B, BSS (100 nM) strongly inhibited IL-8 release in IB3-1 cells. The effect of BSS in IB3-1 cells was verified in CuFi-1 bronchial epithelial cells. As shown in Figure 5, BSS (100 nM) significantly reduces the expression of IL-8 mRNA induced by P. aeruginosa ( Figure 5B). No significant effect of BSS only on IL-8 expression in basal uninfected cells was observed ( Figure 5A). The effect of BSS on the inflammatory response to PAO1 was extended to the analysis of the other major neutrophil chemokines GRO-α, GRO-β. BSS significantly reduced the P. aeruginosa-dependent expression of the neutrophil chemokines IL-8, GRO-α, and GRO-β, both at transcript ( Figure 6A) and protein levels (Figures 6B-D). BSS did not change the basal chemokine release.

BSS Does Not Interfere with Bacterial Growth and Cell Viability
It has been recently reported that BSS extracted from the roots of Caylusea abyssinica has a moderate antibacterial activity against P. aeruginosa, Staphylococcus aureus, and Escherichia coli (Edilu et al., 2015). In order to verify whether the anti-inflammatory effect of BSS was due to its antibacterial property, we measured PAO1 growth in the presence of increasing concentration of BSS (from 0.01 to 200 µM). Figure 5C shows that BSS did not inhibit bacterial growth, at least in our experimental conditions. Therefore, We studied the cell viability of CuFi-1 cells treated with the solvent alone or increasing doses of BSS (0.01-200 µM) for 24 and 48 h. Data shown in Figure 5D demonstrate a cytotoxic effect of BSS only at doses higher than 150 µM.

BSS Reduces the Activation of Protein
Kinase C α Isoform Induced by P. aeruginosa We previously observed that P. aeruginosa interacting with Tolllike Receptors 5 and 2 induces a pro-inflammatory cascade and activation of the intracellular Ca 2+ pathway in which PLCB3 and PKC play key regulatory roles (Bezzerri et al., 2011b). We verified a potential effect of BSS on this latter pathway by investigating its effect on the translocation of the Ca 2+ -dependent PKCα isoform in IB3-1 cells. As shown in Figure 7, BSS (100 nM) significantly reduces the extent of translocation of PKCα to the plasma membrane from 30 to 60 min after P. aeruginosa exposure.

DISCUSSION AND CONCLUSIONS
The urgency of finding more effective anti-infectious and anticancer drugs has newly opened the strategy of drug repurposing, which is aimed to discover new pharmaceutical activities for "old" clinically used drugs. A wide source of molecules for drug repurposing can be found within the natural products of traditional medicine, which provided for many decades significant hints to discover important drugs, that are still in use in several human diseases (for review see Cragg et al., 2014 andCragg, 2016). In search of novel anti-inflammatory molecules to reduce the adverse effects of chronic lung inflammation in CF patients, we were inspired by serendipity on the potential activities of black seeds collected from the deserts of Northern Africa (Morocco) and distributed by Berber pharmacists (Supplementary Text S1). However, safety issues referred to the straight use of extracts from natural products have been raised (Ekor, 2014), which prompted us to identify and test the major single chemical compounds extracted from this natural product. We focused here on extract from the black seeds of N. arvensis. Few data have been reported on "N. arvensis, " e.g., the online PubMed search only recalls seven articles, suggesting mainly generic antimicrobial and anti-inflammatory activities (Landa et al., 2009). Here we found that the extract of N. arvensis has anti-inflammatory activity in bronchial epithelial cells exposed to the Gram-negative bacterium P. aeruginosa (Figures 2, 3), a classical model system to test relevant molecules for CF lung inflammation. We excluded an artifactual effect on cell viability ( Figure 2E) and, being the chloroform extract of N. arvensis active on Gram-positive bacteria (Landa et al., 2009), we also excluded that the anti-inflammatory effect could be mediated by an anti-bacterial activity or by inhibition of bacterium binding to the bronchial epithelial cells (Figures 2C,D). We focused on the three most abundant components extracted with chloroform, which were validated with their pure standards (Table 1), namely BSS, stigmasterol, and campesterol (Figure 1), which are the three most abundant sterols deriving from plants (Valitova et al., 2016). Since plant sterols have been widely tested for efficacy and safety in clinical pharmacology of highly relevant human diseases, such as dyslipidemia related to atherosclerosis, and since consensus has been reached on the absence of adverse signals in large scale clinical trials (Gylling et al., 2014), we felt justified in pursuing a repurposing strategy toward CF lung inflammation. Moreover, different mixtures of these plant sterols have been found of potential immunomodulatory effect (Bouic and Lamprecht, 1999;Bouic, 2002;Yuk et al., 2007).
We found that BSS (100 nM) significantly reduced the expression of the major neutrophilic chemokines IL-8, GROα, and GRO-β in human bronchial epithelial cells challenged with P. aeruginosa. This is consistent with a seminal observation showing that BSS partly reduces IL-8 in skin fibroblasts challenged with retinoic acid (Kim et al., 2003). How could we possibly explain the effect of BSS on neutrophilic chemotaxis? A plant-derived sterol mixture including BSS was found to inhibit the recruitment of neutrophils in a murine model of carrageenan-induced inflammation in vivo (Navarro et al., 2001). The effects of BSS on pro-inflammatory signal transduction have not been extensively investigated, the only hint being that BSS was found to inhibit the active form of the PKCα in prostate-derived cells (Kassen et al., 2000). Here we found that BSS partly reduces the activation of the PKCα isoform in a completely different model, namely the bronchial epithelial cells challenged with P. aeruginosa (Figure 7), which we found involved with a relevant proinflammatory role in the Ca 2+ -dependent signaling machinery, leading to IL-8 gene expression induced by P. aeruginosa in CF bronchial epithelial cells (Bezzerri et al., 2011b). The role of BSS in the organization of lipid rafts of plasma membranes and in the modulation of ceramide (Beck et al., 2007;Hac-Wydro, 2013;Grosjean et al., 2015) also opens interesting insights in relation to sphingolipid metabolism and inflammation in CF lung disease (for review see Aureli et al., 2016).
Taken together, these results suggest that pharmaceutically relevant concentrations of BSS are promising in downmodulating the key neutrophil chemokines strongly induced in bronchial epithelial cells derived from CF patients upon response to P. aeruginosa in vitro (Bezzerri et al., 2011a;Prandini et al., 2016). The large use of BSS in controlled clinical trials, presenting a satisfactory safety profile for long term use (Gylling et al., 2014), stimulates to investigate further on the mechanism(s) of action of this molecule in the CF respiratory models, both in vitro and in vivo, for potential application as an anti-inflammatory molecule complementary to CFTR gene-directed modulators.